title: [The efficacy of exogenous and endogenous interferonization in preventing influenza].
abstract: In this work the results of using interferon (IFN), Dibasol and the combination of these preparations for the urgent prophylaxis of influenza and acute respiratory diseases (ARD) among the employees of the Gamaleia Research Institute of Epidemiology and Microbiology (USSR Acad. Med. Sci.) are summarized. Reaferon and Dibasol decrease ARD morbidity 2 times and leukocytic IFN decreases it 1.4 times, while the combined administration of Dibasol and IFN has proved to be ineffective. Reaferon is mainly a prophylactic remedy; it has been found to bring about almost no decrease in the number of patients at the peak of morbidity, while pronouncedly decreasing it in two weeks after the administration of the preparation. Dibasol has a curative effect, sharply interrupting the beginning rise of morbidity. Reaferon normalizes the characteristics of the IFN status, decreasing the amount of circulating IFN and enhancing the capacity of leukocytes for producing alpha-IFN and gamma-IFN. For the prophylaxis of respiratory infections the use of Reaferon is advisable 3-4 weeks prior to the beginning of the epidemic and then, when the first cases of infection are registered, the course of prophylaxis with Dibasol should be carried out.
authors.forename: F I
authors.initials: FI
authors.lastname: Ershov
authors.forename: S S
authors.initials: SS
authors.lastname: Grigorian
authors.forename: T A
authors.initials: TA
authors.lastname: Semenenko
authors.forename: V V
authors.initials: VV
authors.lastname: Malinovskaia
authors.forename: O A
authors.initials: OA
authors.lastname: Tarasenko
authors.forename: V I
authors.initials: VI
authors.lastname: Agafonov
authors.forename: S V
authors.initials: SV
authors.lastname: Prozorovskiĭ
mesh_terms: D000041:Absenteeism; D001562:Benzimidazoles / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007251:Influenza, Human / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D007369:Interferon Inducers / Q000627:therapeutic use*; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D008875:Middle Aged; D009031:Moscow / Q000453:epidemiology; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D001562:Benzimidazoles; D007369:Interferon Inducers; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; C004453:bendazole; D007372:Interferons
vernacular_title: Effektivnost' ékzogennoĭ i éndogennoĭ interferonizatsii pri profilaktike grippa.